Sudden sensorineural hearing loss (SSNHL) - also known as sudden deafness - is a little known and poorly understood side effect of Covid-19 that is not even listed as a common symptom by doctors ...
A Phase 2 study of SENS-401 was also completed in Sudden Sensorineural Hearing Loss (SSNHL) in January 2022.
to treat Sudden Sensorineural Hearing Loss SSNHL (Phase 2b completed), (ii) to preserve residual hearing following cochlear implantation (Phase 2a completed), and (iii) to prevent Cisplatin ...
A Phase 2 study of SENS-401 was also completed in Sudden Sensorineural Hearing Loss (SSNHL) in January 2022. This press release contains certain forward-looking statements concerning Sensorion and ...
A Phase 2 study of SENS-401 was also completed in Sudden Sensorineural Hearing Loss (SSNHL) in January 2022. www.sensorion.com Label: SENSORION ISIN: FR0012596468 Mnemonic: ALSEN Disclaimer This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results